Trump's Drug-Pricing Plan: Analysis and Implications

This chapter examines President Trump's new drug-pricing plan, focusing on its most favored nation policy designed to lower prescription costs by aligning U.S. prices with those of other developed nations. The discussion highlights skepticism about the plan's implementation, the potential for legal challenges, and the complex negotiations required for its success. It also contrasts the political implications of the plan with reactions from lawmakers, raising questions about the administration's authority and the future of health policy.